ETFs & MarketsBasicArrowhead Regulatory Filing Sets Up Potential Biotech ETF Shifts
Arrowhead Pharmaceuticals is preparing a regulatory filing for its drug candidate plozasiran aimed at treating severe hypertriglyceridemia. This development signals a critical milestone for the company and could influence broader biotech sector sentiment in the coming week.
Published 2 hours ago
Read more →